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Abstract
The requirement of cholesterol for internalization of eukaryotic pathogens like protozoa
(Leishmaniasis, Malaria and  Toxoplasmosis) and the exchange of cholesterol along with other
metabolites during reproduction in Schistosomes  (helminths) under variable circumstances are
poorly understood. In patients infected with some other helminthes, alterations in the lipid profile
have been observed. Also, the mechanisms involved in lipid changes especially in membrane
proteins related to parasite infections remain uncertain. Present review of literature shows that
parasites induce significant changes in lipid parameters, as has been shown in the in vitro study
where substitution of serum by lipid/cholesterol in medium and in experimental models (in vivo).
Thus changes in lipid profile occur in patients having active infections with most of the parasites.
Membrane proteins are probably involved in such reactions. All parasites may be metabolising
cholesterol, but the exact relationship with pathogenic mechanism is not clear. So far, studies
suggest that there may be some factors or enzymes, which allow the parasite to breakup and
consume lipid/cholesterol. Further studies are needed for better understanding of the mechanisms
involved in vivo. The present review analysis the various studies till date and the role of cholesterol
in pathogenesis of different parasitic infections.
Introduction
Parasitic protozoa and helminthes are responsible for
some of the most devastating and prevalent diseases of
humans, threatening the lives of nearly one-third of the
worldwide human population leading to more than 2
million deaths annually. Habitats of parasites are
extremely varied and common parasites of man (proto-
zoa, helminthes and arthropods) normally inhabit the
intestine, blood, liver, lungs brain, muscles and lymphatic
tissues [1]. Many species of parasites have complex life
cycles involving developmental stages that live in soil or
water, or use various kinds of intermediate hosts, includ-
ing vertebrates and invertebrates and cold and warm-
blooded animals. In such varied environments, parasites
have become adapted to using/tolerating widely differing
oxygen, carbon dioxide, hydrogen ion concentrations and
temperatures [1]. Their nutritional requirements and their
means of obtaining and utilizing the nutrients required
for growth, motility and reproduction are also varied. The
requirement of cholesterol for internalization of eukaryo-
tic pathogens under such variable circumstances is poorly
understood.
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The present review highlights the role of lipids and their
metabolical mechanisms in protozoan and helminthic
infections.
Cholesterol is a major constituent of eukaryotic mem-
branes and plays a crucial role in cellular membrane
organization, dynamics, function and sorting. It is often
found distributed non-randomly in domains in mem-
branes [2]. Recent observations suggest that cholesterol
exerts many of its actions by maintaining a specialized
type of membrane domain, termed "lipid rafts" in a func-
tional state. Lipid rafts are enriched in cholesterol and
sphingolipids, and have been thought to act as platform
through which signal transduction events are coordinated
and pathogens gain entry to infect host cells [3].
Relationship of serum cholesterol levels in man infected
with parasites has drawn the attention of various workers.
Since it has been shown in-vitro studies that parasites like
Giardia and Entamoeba can grown in lipid rich media in
the absence of serum, it would be interesting to determi-
nate the mechanism of lipid/cholesterol utilization.
Recent studies have shown elevated levels of lipoproteins
like high density lipoprotein (HDL), low density lipopro-
tein (LDL) and total cholesterol in patients suffering from
parasitic infection (4). In human body cholesterol is syn-
thesized in liver, which incidentally happens to be a major
extraintestinal site of infection with Entamoeba histolytica.
Keeping this in view, the following queries arise (i) is
there any correlation between cases of amoebic liver
abscess (ALA) with cholesterol synthesis in liver? (ii) in
case of intestinal amoebiasis, what is the source of choles-
terol? (iii) how do the amoebae utilize cholesterol in
these two different areas (iv) what is the role of cholesterol
in enhancing virulence and pathogenecity of E. histolytica
(v) does cholesterol help in cyst formation?
Entamoeba, Giardia  and trichomonads form what can be
usually termed as 'mucosal parasites' which lack mito-
chondria, well developed golgi complexes, and other
organelles typical of higher eukaryotes [1]. These parasites
have developed unique metabolic pathways that allow
them to survive and multiply by scavenging nutrients
from the host, but are unable to synthesize the majority of
their own lipids and cholesterol de novo [5]. Therefore, an
understanding how they transport and utilize exogenous
lipids for metabolic purposes is extremely important?
There is evidence suggesting that these parasites can take
up the lipids and cholesterol they need from lipoprotein
particles present in the host gut and tissue in vivo and
from the growth medium in vitro. Exogenous phospholi-
pids have been shown to undergo fatty acid remodeling
[by deacylation/reacylation reactions], which allow these
protozoa to alter lipids, bypassing the synthesis of entirely
new phospholipid molecules [5].
The endocytic process is essential for uptake of nutrients
and other molecules by protozoan parasites. Membrane
dynamics in endocytosis has been investigated in para-
sites such as Leishmania and Trypanosoma. The receptor-
mediated endocytosis of LDL by Schistosoma mansoni has
been reported [6]. A putative LDL-receptor has been iden-
tified on the tegument and gut lining from Schistosoma
japonicum adult worms [7] and schistosomula of S. man-
soni [8]. Recently, Coopens et al [9] demonstrated that the
intracellular parasite, Toxoplasma gondii, acquires host
cholesterol that is endocytosed by the LDL pathway, a
process that is specifically increased in infected cells. Inter-
ference with LDL endocytosis or cholesterol translocation
reduced the intracellular survival of T. gondii [9]. In a clas-
sic experiment, Aley et al [10] demonstrated the phenom-
enon of endocytosis through non-acidified vesicles in E.
histolytica. They showed that these non-acidified vesicles
(distinct from intracellular acidified vesicles) were derived
from plasma membranes and played important roles in
endocytosing nutrients and other biological molecules
into cells.
Cholesterol – biosynthesis and metabolism
Cholesterol is an amphipathic lipid and as such is an
essential structural component of all cell membranes and
of the outer layer of plasma lipoproteins. It is present in
tissues and in plasma lipoprotein either as free cholesterol
or, combined with a long-chain fatty acid, as cholesteryl
ester. It is synthesized in many tissues from acetyl-CoA
and is ultimately eliminated from the body in the bile as
cholesterol or bile salts [11]. Lipoprotein transports free
cholesterol in the circulation, where it readily equilibrates
cholesterol in other lipoproteins and in membranes.
Cholesteryl ester is a stored form of cholesterol found in
most tissues. It is transported as cargo in the hydrophobic
core of lipoproteins [12]. So, the fact that cholesterol in a
hydrophobic molecule, which resides in lipoproteins and
cell membranes, raises two questions: (i) how does the
cell sense the level of cholesterol? (ii) how in this choles-
terol specific signaling transmitted to the nucleus for the
regulation of various genes?
Recent studies directed to resolve these questions, led to
the discovery of a novel cell surface cholesterol-sensor
designated as receptor-Ck which was not only shown to
be ubiquitously present in various human organs but also
[through its signaling pathway] regulated various genes
involved in cholesterol homeostasis [HMG CoA synthase;
HMG CoA reductase; apo 'B'- specific LDL – receptor] cell
growth [cyclin 'D'; C – fos; C-myc; p27 etc]; cell death
[Bc1-2] through a 47 KDa transcription factor [derived
from the cleavage of 125 KDa SREBP] having affinity for
genomic sterol regulatory element [SRE] sequence as well
as through other transcription factors [13-17].Lipids in Health and Disease 2005, 4:10 http://www.lipidworld.com/content/4/1/10
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Anaerobic parasites
Entamoeba
Entamoeba histolytica parasitizes the gastro-intestinal tract
of humans and is a major cause of morbidity and mortal-
ity in tropical and subtropical countries [18]. Although
several successive life cycle stages of E. histolytica have
been documented, briefly, it can be classified into two
main morphologic forms, i.e. trophozoites and cysts. In E.
histolytica, excystation occur in the small intestine, where
four amoebae are released from the mature quadri nucle-
ate cyst. Trophozoites dwell in the colon, where they mul-
tiply and encyst typically producing four nucleated cyst
[19]. Cholesterol has been reported to be a growth – pro-
moting factor of E. histolytica [20]. The virulence of a viru-
lent strain could be revived in vitro by adding cholesterol
to medium or in vivo by feeding cholesterol to experimen-
tal animals or the host [21-23]. Cholesterol is thought to
act as an irritant to mucus membrane and thereby helps
the amoebae to establish and colonize at the injured site
and this enhances the virulence [24]. In-vitro study has
shown that substitution of lipid/cholesterol instead of
serum, supported vigorous growth of E. histolytica in
axenic culture [25].
Recently, Laughlin et al [26] have shown that the disrup-
tion of cholesterol rich raft-like membrane domains in
Entamoeba with the cholesterol-binding agent filipin and
methyl-β -cyclodextrin inhibit several important virulence
functions, fluid phase pinocytosis and adhesion to host
cell monolayers. However, disruption of raft-like domains
did not inhibit constitutive secretion of cysteine proteases,
another important virulent function of Entamoeba.
Cysteine proteinases in Entamoeba are likely to be associ-
ated with tissue invasion and pathogenesis [27]. Andra et
al [28], revealed that the lipid composition of amoebic
membranes prevents binding of the cytolytic molecules
and that both the phospholipid ingredients and the high
content of cholesterol contributes to the protection of the
toxin-producing cell.
More recently the authors have assessed the impact of
lipid parameter in patients infected with E. histolytica and
E. dispar. The result showed significant lower levels of
lipid profile [total cholesterol, HDL & LDL] in E. histolytica
and E. dispar cyst passers and ALA patients as compared to
healthy controls. Also, cyst passers had lower levels of
cholesterol than ALA cases [29].
Giardia
Giardiasis is the most common waterborne disease in
human, which is caused by an enteric flagellated proto-
zoan Giardia lamblia. Giardia is widespread with children
being the most vulnerable [30]. Giardia exists in two mor-
phologic forms: trophozoite and cysts. In G. lamblia,
excystation is accomplished in two steps first by limiting
the acidic conditions present in the stomach and secondly
by the protease-rich and slightly alkaline small intestine.
Encystation, in turn, can be induced in vitro by starving
the trophozoites of cholesterol, either by using lipopro-
tein-deficient serum or augmenting the bile concentration
in the culture medium [31,32]. Membrane biogenesis in
Giardia  requires cholesterol [33,34]. Because Giardia  is
unable to synthesize cholesterol [33] it obtains the same
from upper small intestine, which is rich in biliary and
dietary cholesterol [35,36]. Effects of bile salts on encysta-
tions are directly related to the uptake of cholesterol by
the trophozoites [37].
In vitro, it was observed that replacing bovine serum with
a lipoprotein cholesterol (LPC) solution and bovine
serum albumin in pre-encystation and excystation media,
stimulated G.1amblia encystations and encystation spe-
cific secretory vesicles (ESV) formation [38]. It is estab-
lished that cholesterol-dependent down-regulation of
encystations-specific CWP-1 gene expression has contrib-
uted to the inhibition of Giardia  encystation process
[31,37]. Previously, we have reported that receptor Ck
dependent signaling is responsible for the regulation of
Giardia encystations process by cholesterol [39]. Recently
we have observed that patients infected with G. lamblia
showed lower levels of lipid parameters (total cholesterol,
HDLc and LDLc) as compared to control healthy group
[29].
Trichomonas
Trichomonas vaginalis is a sexually transmitted protozoan
parasite, adheres to the vaginal epithelium, causing vagin-
itis and other complications in women [40]. It is an anaer-
obic protozoan flagellate, which lacks mitochondria and
peroxisomes, but has a specialized double-membrane-
bounded organelle called the hydrogenosome, which is
involved in metabolic processes that extend glycolysis
[41]. In vitro study has shown that when serum was
replaced by bovine serum albumin and cholesterol, it
resulted in good growth [42].
Apicomplexan parasites
Plasmodium
Plasmodium falciparum is the most pathogenic species
causing human malaria. Erythrocytes become infected fol-
lowing attachment and invasion by merozoite. Various
phases of parasite development can be observed during
the 48 h – erythrocytic cycle i.e. rings, trophozoites and
schizonts. In vitro the parasite grows in 5–10% human
serum in an atmosphere of low oxygen [43]. Very little is
known about mechanism involved in lipid changes
related to malaria. Hypercholesterolemia and hypertrig-
lyceridemia was observed in both uncomplicated and
complicated malaria [44-46], whereas Kittl et al [47], have
shown no correlation between severity of malaria attacksLipids in Health and Disease 2005, 4:10 http://www.lipidworld.com/content/4/1/10
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and extent of HDL – cholesterol decrease. Human serum
HDL is necessary for P. falciparum in in vitro culture. How-
ever, it has been reported that HDL can be toxic for the
parasite at high concentrations [48].
Recently, Imrie et al [49], have also reported that in the
absence of serum, HDL in low concentration (0.75 mg/
ml) supported growth of P. falciparum in vitro, whereas at
high concentration (3 mg/ml), it was toxic to the parasite.
Recent findings, however, would suggest that the plasmo-
dium genome contains genes encoding enzymes of phos-
pholipids metabolism, allowing de novo synthesis of
phosphatidyl choline via the knneddy pathway and neces-
sitating only the uptake of the small choline molecule
[50]. In addition, the genome of P. falciparum contains
genes similar to those for type II fatty acid synthesis path-
way. The protein products of these genes are located
within the apicoplast and allow for the production of fatty
acids, some of which are unique to the parasite [50]. Thus
the parasite may be able to meet many of its lipid require-
ments from its own biosynthetic pathways, although
some extracellular lipids are necessary for in vitro growth.
It has also been seen that plasma membrane cholesterol
plays a role in the pathogenesis of immune evasion and
clinical manifestations of falciparum malaria [51].
There are few studies which suggest that there are changes
in lipid plasma or serum levels in-vivo after infection. But,
no significant changes were seen in the plasma cholesterol
during and after infection of malaria [52]. However, low
levels of the cholesterol in patients infected with malaria
as compared to normal healthy controls have been
reported [53]. In another study changes in plasma lipo-
protein was seen in acute malaria resulting decreased lev-
els of HDL and LDL and moderately increased
triglycerides [54]. In malaria endemic areas, when plasma
levels of cholesterol, triglcerides, HDLc and LDLc were
analysed in children infected with P. falciparum, investiga-
tors have found significantly low levels of lipid profile
[55]. Brotons et al [56] reviewed that population studies
on common lipid parameters and observed that choles-
terol values are lower in Africa, where, malaria is endemic,
than in many other parts of the world.
Toxoplasma
Toxoplasma gondii, an apicomplexan protozoan parasite, is
an important pathogen of humans and animals. It is
widely distributed with a very high prevalence in many
regions, and can cause serious infections in immuno-
compromised patients (particularly AIDS patients) and in
the developing fetus [57]. Host cell cholesterol is impli-
cated in the entry and replication of an increasing number
of intracellular microbial pathogens. However, recently
new mechanism has been described by which host choles-
terol specifically controls entry of an intracellular patho-
gen. Briefly, the parasitophorus vacuole membrane
(PVM) surrounding T. gondii contains cholesterol. At the
time of cell entry host plasma membrane cholesterol is
incorporated into the forming PVM during invasion,
through a caveolae independent mechanism. Depleting
host cell plasma membrane cholesterol blocks parasite
internalization by reducing the release of rhoptry proteins
that are necessary for invasion [58].
In another study, Coppens et al [9] had shown that T. gon-
dii exploits host low density lipoprotein receptor-medi-
ated endocytosis for cholesterol acquisition. Whereas,
acyl-CoA: cholesterol acyl transferase (ACAT) and choles-
terol esters play a crucial role in the optimal replication of
T. gondii [59]. These studies indicate the cholesterol does
have a role in the pathogenesis of Toxoplasmosis.
Cryptosporidium
Heterogeneous distribution of membrane cholesterol at
the attachment site of Cryptosporidium muris to host cells
has already been investigated. Although many filipin-cho-
lesterol complexes were observed on the plasma mem-
brane of host cells and parasites, a line showing no
complexes was evident at the above two membrane junc-
tures. These observations indicate that parasitic infection
of C. muris altered the organization of membrane choles-
terol [60]. The exact role of cholesterol in pathogenesis/
virulence of parasite needs to be determined.
Kinetoplastid parasites
Leishmania
Leishmania is an obligate intracellular parasite that infects
macrophages of the vertebrate host, resulting in visceral,
cutaneous and mucocutaneous leishmaniasis in humans.
Recently Pucadyil [61] reported that plasma membrane
cholesterol is required for efficient attachment and inter-
nalization of the parasite in macrophages, leading to
Leishmania donovani infection. Rodrigues et al [62] have
shown that when amastigotes and promastigotes forms of
L. amzonensis are incubated with 22,26-azasterol, which is
a delta (24(25))-sterol methyltransferase (SMT) inhibitor,
it results in arrest of growth. They also observed that alter-
ation occur in the lipid composition of the parasite mem-
brane, resulting in loss of viability. The study suggests the
use of 24-SMT inhibitor could be used as selective
antileishmanial agent. Dietz et al [63] have reported suc-
cessful treatment of Brazilian kala-azar using lipid encap-
sulated amphotericin B. Thus, a level of cholesterol in the
patients infected with leishmaniasis has to be determined.
Trypanosoma
African trypanosomes are lipid auxotrophs that live in the
bloodstream of their human and animal hosts and are
unable to synthesize cholesterol but appear to bind and
take up plasma low-density lipoproteins (LDL) from theirLipids in Health and Disease 2005, 4:10 http://www.lipidworld.com/content/4/1/10
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host [64]. Whether cholesterol homeostasis of this unicel-
lular parasite also requires interactions with host high-
density lipoprotein (HDL) particles is unknown. Trypano-
somes require lipoproteins to multiply under axenic cul-
ture conditions [65]. Recently, Green et al [66] reported
that HDL, LDL, and trypanosome lytic factor (TLF1) were
bound and taken up by a lipoprotein scavenger receptor,
which may constitute the parasite's major pathway medi-
ating the uptake of essential lipids. Frequent turnover of
variable surface glycoproteins is a well established
method of immune evasion by Trypanosomes. Does it
involve the role of HDL, LDL, and TLF1 in getting elimi-




It has been shown that Schistosome  infection could be
counteracting the effects of an atherogenic diet by modu-
lating host lipid metabolism and inducing a reduction in
blood total cholesterol concentration [67]. Little informa-
tion is available on the lipid changes caused by S. mansoni
reinfection. Popiel et al [68], studied the metabolism of
cholesterol uptake by paired and unpaired worms of S.
mansoni during pairing, the results showed labeled worms
lost upto 65% of their cholesterol. This suggests that nor-
mal cholesterol transfer in worm pairs is bi-directional
and that it is facilitated by physical contact between juxta-
posed membranes. Cholesterol exchange in schistosome
worm pairs may be partly or wholly consequences of nor-
mal tegumental turnover of the molecule.
In another study Silveira et al [69] investigated the transfer
of cholesterol and its metabolites between adult male and
female worms of S. mansoni. They found that the adult
male and female worms of S. mansoni are able to incorpo-
rate cholesterol and convert it into several metabolites.
On the other hand, Schistosomula  cannot convert the
incorporated cholesterol. However, a significant reduc-
tion in levels of serum lipid profile was observed in mice
infected with S. mansoni [70]. These changes might be
attributed to several metabolites released by S. mansoni,
which affect the host hepatic tissue resulting in decreased
synthesis of these parameters and their release into the cir-
culation. The ability of Schistosomula to convert choles-
terol into its metabolites, shows that it is a property
acquired, used by adults only and is specifically active dur-
ing pairing. What is the exact role of cholesterol during
pairing needs to be investigated. What happens to choles-
terol levels in serum of patients also needs to be studied.
Intestinal worms
In-vivo study has shown the decreased serum lipid levels
in the Shipibo population (Peru), showed a significant
inverse correlation between worm egg excretion and HDL
levels in hookworm, Strongyloides and Trichuris infected
patients but not in Ascaris infected cases [71]. The mecha-
nisms underlying the observed association between intes-
tinal worm load and HDL reduction are not completely
understood and may include reduced HDL synthesis in
the gut wall due to inflammatory toxic irritation. Hence,
cholesterol may have a role in pathogenesis by helping the
larvae to survive in the host tissue.
Ascaris
During larval ascariasis the metabolism of lipids is signif-
icantly disturbed. Decreased levels of total cholesterol,
HDL cholesterol and triglycerides were observed in guinea
pigs. The changes are due to the break in liver function
and, presumably, changes in hormone secretion, which
are provoked by the presence of the parasite [72]. It has
also been seen that cholesterol enhanced larval survival
and the yield and growth of L4 of A. summ larvae when
added to RPMI-1640 culture medium [73].
Ancylostoma
In vitro A. duodenalis grown axenically in medium supple-
mented with cholesterol gives good growth [74]. Phos-
pholipid/cholesterol ratio in liver plasma membrane of
the infected golden hamsters with A. ceylanicum group was
significantly reduced, which suggest that both the struc-
tural and functional organization of membrane may be a
biochemical basis of the hepatotoxic effects [75].
Filaria
Decreased levels of lipid contents were observed in liver of
Mastomys natalensis during the development of B. malayi
infection [76]. The lipid peroxide formation was
enhanced in liver during the development of filarial infec-
tion. The studies in human beings are lacking.
Hymenolepis
Balb/c mice infected with Hymenolepis microstoma signifi-
cantly affected the lipid metabolism [77]. The changes
were in relation to nutritional interactions between host
and parasite and the possible effect on host hormone lev-
els. Johnson et al [78] studied on the mechanisms of cho-
lesterol uptake by the rat tapeworm H. diminuta. The
results support the hypothesis that the tapeworm absorbs
cholesterol by a specific carrier-mediated process. Choles-
terol uptake is reduced when the capacity of the micellar
phase of the medium is increased, suggesting that uptake
involves the intermediate partitioning of sterol from
micelles into the aqueous phase of the medium [79].
Conclusion
The mechanisms involved in lipid changes related to par-
asite infections remain uncertain. Cholesterol starvation
initiates encystations. This indicates that cholesterol has a
role in pathogenesis as it helps the parasite to remain inLipids in Health and Disease 2005, 4:10 http://www.lipidworld.com/content/4/1/10
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trophozoite stage. However, many workers have investi-
gated that medium containing lipoproteins supported the
growth of the parasites in vitro. It is possible that all these
parasites use LDL-like receptors to endocytose various
lipoprotein particles. However, typical receptor binding
affinity, number of LDL-receptors exposed on cell sur-
faces, receptor internalizations etc. in mucous-dwelling
parasites are not known. Few population based studies
showed altered lipid profiles in patients infected with
malaria compared to asymptomatic control group. So, to
evaluate the impact of malaria on lipid parameters at the
population levels in different age groups, studies are
needed to explore the relevance of this finding in different
patterns of hyperendemic regions. The association of par-
asites and the contents of their membranes before pene-
tration/invasion and realignments seen after attachment
need to be studied. Also, the role of PVM and their con-
tents in protection of parasites within PVM also need to be
studied.
So far, the studies suggest that there may be some factors
or enzymes, which allow the parasite to breakup and con-
sume lipid/cholesterol. Further studies are needed for bet-
ter understanding of the mechanisms involved in vivo.
Future strategies
The evidence suggests that parasites are able to remodel/
metabolize host lipids for their growth and to generate
phospholipids membrane. So, the identification and
characterization of more enzymes involved in these path-
ways will be more important for the proper understand-
ing of these steps. Recent progress in molecular biology
and parasite genome projects will assist researchers in the
near future to identify the genes and enzymes of lipid met-
abolic pathways.
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